Scattered regulatory sources
Updates may appear across regulations, guidance documents, recognized standards, safety communications, submission programs and compliance materials.
Monitor the FDA, quality-system, premarket, clinical, labeling, reporting, postmarket and cybersecurity sources your organization selects. When something changes, RegWatch helps regulatory, quality, clinical, engineering and security teams understand what changed, what may be affected and what to review next.
Requirements and guidance may come from FDA regulations, CDRH programs, recognized consensus standards, premarket pathways, inspection materials and state authorities. RegWatch brings the sources you select into a consistent monitoring and review process.
Updates may appear across regulations, guidance documents, recognized standards, safety communications, submission programs and compliance materials.
Watchlists may need to reflect device classification, product code, submission type, establishment role, technology and market status.
Teams need a repeatable way to connect new requirements with procedures, design controls, risk files, labeling and postmarket processes.
Reviewers need the source, dates, affected topics and a clear path to assign regulatory, quality, engineering and security follow-through.
Select the regulations, guidance, standards and program materials that matter to your products and operations. Expand coverage as portfolios, technologies, establishments and obligations change.
Selected FDA QMSR and 21 CFR Part 820 materials, ISO 13485-related sources, inspection programs, quality-system guidance and recognized standards.
Selected 510(k), De Novo, PMA, IDE, Q-Submission, eSTAR and product-specific FDA guidance relevant to your regulatory strategy.
Establishment registration and device listing, UDI and GUDID materials, labeling requirements and selected product-identification sources.
Medical Device Reporting under 21 CFR Part 803, corrections and removals under Part 806, recalls, safety communications and surveillance materials.
Selected IDE, human-subject protection, institutional review board, design and development, risk-management and clinical evidence sources.
Selected FDA digital-health and cybersecurity guidance, FD&C Act section 524B materials, software documentation and postmarket vulnerability sources.
Monitor availability and applicability vary by source, device, establishment role and organization. Your team chooses the watchlist it wants RegWatch to follow.
Select your monitors, receive organized change intelligence and optionally connect policies for gap assessment.
Choose the regulations, FDA programs, guidance, standards, product areas and postmarket sources your organization wants to follow.
See what changed, important dates, affected requirements, source links and suggested review areas.
Upload and assign quality procedures, regulatory plans, risk files, labeling controls, cybersecurity documents or reporting procedures.
Review potential document gaps, clarification or remediation needs, ownership, review activity and supporting evidence.
RegWatch follows the regulation, guidance, standard, safety communication or program source your team selects.
The update is captured, summarized and organized so reviewers can focus on what changed.
Your team receives a focused review package instead of another unstructured alert.
RegWatch can support organizations with different device classes, submission pathways, manufacturing roles and technology profiles—without forcing every product team into the same watchlist.
Create your free monitoring accountReduce repeated searches across individual FDA, standards, safety and program websites.
Give owners the source, dates, affected lifecycle topics and review context in one place.
Connect selected requirements with the quality procedures, controls and records your teams rely on.
Keep updates, assessments, assignments, decisions and supporting evidence organized.
Start with regulatory monitoring, then add policy assessment workflows when your team is ready.
Talk to AllgressCompanies can build watchlists from available selected sources such as FDA regulations and guidance, the Quality Management System Regulation, recognized consensus standards, premarket submission materials, Medical Device Reporting, corrections and removals, establishment registration and listing, UDI, labeling, clinical investigation, and cybersecurity sources. Available coverage depends on the selected monitors and sources.
RegWatch can monitor selected QMSR and related FDA sources when those monitors are available and chosen by your organization. The revised 21 CFR Part 820 became effective on February 2, 2026 and incorporates ISO 13485:2016 by reference, with additional FDA requirements. Your organization remains responsible for determining applicability and implementation.
Yes. You can use RegWatch for regulatory monitoring and change alerts without uploading procedures or quality documents. Uploads are optional and enable policy and document assessment workflows.
You assign uploaded quality procedures, design and development documents, complaint-handling procedures, reporting procedures, labeling controls, cybersecurity plans or other documents to relevant monitors. When selected requirements change, RegWatch can identify areas that may require review, clarification or remediation.
No. RegWatch provides regulatory intelligence, workflow support and document assessment assistance. Your organization remains responsible for device classification, regulatory strategy, applicability decisions and obtaining legal, quality, clinical or regulatory advice where needed.
Get a free RegWatch account and begin building your organization’s monitoring watchlist.